NB

Neetu Bohra

Active Director Director DIN 08262118
DIN 08262118 First appointment Oct 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Neetu Bohra

Data last updated:

Neetu Bohra is a Director at Candid Pharma Private Limited (since 2018). The company operates in Pharma.

DIN 08262118
Primary Designation Director
Industry Pharma
First Appointment 23 Oct 2018
Oldest Company Age 17 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Candid Pharma Private Limited U24239GJ2009PTC057983
Director23 Oct 20182009Active

Board colleagues of Neetu Bohra

NameDINCompanyDesignation
Ashish Bohra01792641Candid Pharma Private LimitedDirector
Urmila Bohra02458003Candid Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Candid Pharma Private Limited
Premium access

Shareholding and investment profile for Neetu Bohra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neetu Bohra

Neetu Bohra currently holds 1 directorship: Candid Pharma Private Limited (Director, since 23 Oct 2018).

Neetu Bohra was first appointed on 23 Oct 2018 as Director at Candid Pharma Private Limited.

The current boards of Neetu Bohra's companies include Ashish Bohra (Candid Pharma Private Limited), Urmila Bohra (Candid Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available